Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

Keratin 17 is important for skin's response to radiation, affecting many genes and cell division.

Keratin 17 is important for skin development and may help define skin cell types.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Cholecystokinin may help reduce skin inflammation in psoriasis.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Retinol may affect immune responses in people with frequent skin boils.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Tph cells are linked to the severity of systemic lupus erythematosus.

PCOS is linked to low-grade chronic inflammation.

Different parts of the body have unique immune characteristics in their skin.

A new IL6ST gene variant may cause a unique form of hyper-IgE syndrome with skin abscesses and high IgE levels.